112 related articles for article (PubMed ID: 19887755)
1. Activation of PI3K-AKT pathway in oral epithelial dysplasia and early cancer of tongue.
Watanabe S; Sato K; Okazaki Y; Tonogi M; Tanaka Y; Yamane GY
Bull Tokyo Dent Coll; 2009 Aug; 50(3):125-33. PubMed ID: 19887755
[TBL] [Abstract][Full Text] [Related]
2. Potential markers of tongue tumor progression selected by cDNA microarray.
Carinci F; Lo Muzio L; Piattelli A; Rubini C; Chiesa F; Ionna F; Palmieri A; Maiorano E; Pastore A; Laino G; Dolci M; Pezzetti F
Int J Immunopathol Pharmacol; 2005; 18(3):513-24. PubMed ID: 16164832
[TBL] [Abstract][Full Text] [Related]
3. LAMC2 is a predictive marker for the malignant progression of leukoplakia.
Nguyen CT; Okamura T; Morita KI; Yamaguchi S; Harada H; Miki Y; Izumo T; Kayamori K; Yamaguchi A; Sakamoto K
J Oral Pathol Med; 2017 Mar; 46(3):223-231. PubMed ID: 27529842
[TBL] [Abstract][Full Text] [Related]
4. Silencing of SPP1 Suppresses Progression of Tongue Cancer by Mediating the PI3K/Akt Signaling Pathway.
Zhang Q; Li L; Lai Y; Zhao T
Technol Cancer Res Treat; 2020; 19():1533033820971306. PubMed ID: 33174521
[TBL] [Abstract][Full Text] [Related]
5. PI3K-AKT-mTOR pathway proteins are differently expressed in oral carcinogenesis.
Martins F; de Sousa SC; Dos Santos E; Woo SB; Gallottini M
J Oral Pathol Med; 2016 Nov; 45(10):746-752. PubMed ID: 26991907
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein and p-Akt proteins in oral dysplasia and in oral squamous cell carcinoma: an immunohistochemical study.
Pontes HA; de Aquino Xavier FC; da Silva TS; Fonseca FP; Paiva HB; Pontes FS; dos Santos Pinto D
J Oral Pathol Med; 2009 Sep; 38(8):644-50. PubMed ID: 19453843
[TBL] [Abstract][Full Text] [Related]
7. MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway.
Ishibashi O; Akagi I; Ogawa Y; Inui T
Biochem Biophys Res Commun; 2018 Jun; 501(2):507-513. PubMed ID: 29738771
[TBL] [Abstract][Full Text] [Related]
8. Investigation of environmental factors for diagnosing malignant potential in oral epithelial dysplasia.
Okazaki Y; Tanaka Y; Tonogi M; Yamane G
Oral Oncol; 2002 Sep; 38(6):562-73. PubMed ID: 12167434
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma.
Matta A; Tripathi SC; DeSouza LV; Grigull J; Kaur J; Chauhan SS; Srivastava A; Thakar A; Shukla NK; Duggal R; DattaGupta S; Ralhan R; Michael Siu KW
Int J Cancer; 2009 Sep; 125(6):1398-406. PubMed ID: 19548310
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
12. mRNA expression of the DNA replication-initiation proteins in epithelial dysplasia and squamous cell carcinoma of the tongue.
Li JN; Feng CJ; Lu YJ; Li HJ; Tu Z; Liao GQ; Liang C
BMC Cancer; 2008 Dec; 8():395. PubMed ID: 19116018
[TBL] [Abstract][Full Text] [Related]
13. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
Zhang H; Sun JD; Yan LJ; Zhao XP
Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
[TBL] [Abstract][Full Text] [Related]
14. Expression of von Hippel-Lindau tumor suppressor protein (pVHL) characteristic of tongue cancer and proliferative lesions in tongue epithelium.
Hasegawa H; Kusumi Y; Asakawa T; Maeda M; Oinuma T; Furusaka T; Oshima T; Esumi M
BMC Cancer; 2017 May; 17(1):381. PubMed ID: 28549422
[TBL] [Abstract][Full Text] [Related]
15. FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop.
Yang H; Wen L; Wen M; Liu T; Zhao L; Wu B; Yun Y; Liu W; Wang H; Wang Y; Wen N
Anticancer Drugs; 2018 Mar; 29(3):216-226. PubMed ID: 29360662
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical Expression of Podoplanin in Clinical Variants of Oral Leukoplakia and Its Correlation With Epithelial Dysplasia.
D'souza B; Nayak R; Kotrashetti VS
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):132-139. PubMed ID: 27153448
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
[TBL] [Abstract][Full Text] [Related]
19. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy.
Li B; Xu WW; Lam AKY; Wang Y; Hu HF; Guan XY; Qin YR; Saremi N; Tsao SW; He QY; Cheung ALM
Oncotarget; 2017 Jun; 8(24):38755-38766. PubMed ID: 28418888
[TBL] [Abstract][Full Text] [Related]
20. Assessment of c-Jun, c-Fos and cyclin D1 in premalignant and malignant oral lesions.
Turatti E; da Costa Neves A; de Magalhães MH; de Sousa SO
J Oral Sci; 2005 Jun; 47(2):71-6. PubMed ID: 16050486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
